Holen Sie sich die Stockscreener-App
22.47
0.99%
0.22
Handel nachbörslich:
22.47
Schlusskurs vom Vortag:
$22.25
Offen:
$22.23
24-Stunden-Volumen:
317.95K
Relative Volume:
1.16
Marktkapitalisierung:
$789.01M
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
60.73
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
+15.35%
1M Leistung:
+17.89%
6M Leistung:
-5.79%
1J Leistung:
+26.95%
1-Tages-Spanne:
$22.16
$22.88
1-Wochen-Bereich:
$18.89
$22.88
52-Wochen-Spanne:
$16.16
$26.55
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
22.47 | 789.01M | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Phibro Animal Health (NASDAQ:PAHC) Trading 12.6% Higher Following Better-Than-Expected Earnings - Defense World
Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and Strategic Investments Propel Performance - GuruFocus
Earnings call transcript: Phibro Animal Health beats Q3 2025 expectations - Investing.com
Phibro Animal Health (PAHC) Target Price Raised to $21 by Morgan Stanley | PAHC Stock News - GuruFocus
Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge - Investing.com Canada
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $21 From $20, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts Phibro Animal Health (PAHC) Price Target Following Q3 Performance | PAHC Stock News - GuruFocus
Envestnet Asset Management Inc. Buys New Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Reports Strong Q3 Results - TipRanks
Phibro: Fiscal Q3 Earnings Snapshot - MySA
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates - Yahoo Finance
Phibro Animal Health Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Phibro (PAHC) Sees Strong Q3 with Significant Gains in Animal Health Segment | PAHC Stock News - GuruFocus
Phibro Animal Health Corp Reports Q3 EPS of $0.51, Beating Estimates; Revenue at $347.8 Million, Slightly Below Expectations - GuruFocus
Earnings Flash (PAHC) Phibro Animal Health Posts Q3 Revenue $347.8M, vs. FactSet Est of $352.2M - marketscreener.com
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance - Stock Titan
Phibro Animal Health Sets June Dividend: What Shareholders Need to Know About the $0.12 Payout - Stock Titan
Phibro Animal Health Corp expected to post earnings of 52 cents a shareEarnings Preview - TradingView
Raymond James Financial Inc. Acquires Shares of 52,503 Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
BlackRock, Inc. Reduces Stake in Phibro Animal Health Corp - GuruFocus
Wells Fargo & Company MN Acquires 2,247 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Earnings: Key Q3 Financial Results Coming May 7 After Market Close - Stock Titan
Geode Capital Management LLC Grows Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health price target lowered to $18 from $22 at BofA - Yahoo Finance
Phibro Animal Health (PAHC) Faces Reduced Price Target Amid Nega - GuruFocus
BofA Securities Adjusts Price Target on Phibro Animal Health to $18 From $22, Maintains Underperform Rating - marketscreener.com
Phibro Animal Health Corp [PAHC] Director makes an insider purchase of 5,000 shares worth 0.11 million. - knoxdaily.com
PAHC or BSX: Which Is the Better Value Stock Right Now? - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks - Yahoo Finance
Alliancebernstein L.P. Acquires 101,560 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
LPL Financial LLC Grows Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Morgan Stanley Adjusts Price Target for Phibro Animal Health (PAHC) | PAHC Stock News - GuruFocus
Should You Be Concerned About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE? - Yahoo Finance
Corebridge Financial Inc. Trims Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Wellington Management Group LLP Has $1.72 Million Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks - Yahoo Finance
What is Zacks Research’s Forecast for PAHC Q3 Earnings? - Defense World
Here is Why Growth Investors Should Buy Phibro (PAHC) Now - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
Thrivent Financial for Lutherans Sells 1,776 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Sei Investments Co. Has $3.40 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Acquired by American Century Companies Inc. - Defense World
Quantbot Technologies LP Acquires 2,018 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance
Should You Bet on PAHC Stock at a Discounted P/E of 10.41X? - MSN
Charles Schwab Investment Management Inc. Increases Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice - Yahoo Finance
Amundi Boosts Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):